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Abstract 
Objectives: Endodontic management of open apex using MTA and platelet – rich fibrin membrane as an apical 
matrix barrier.
Study design: An immature tooth with pulpal necrosis and periapical pathology imposes a great difficulty to the 
endodontist. Endodontic treatment options for such teeth consist of conventional apexification procedure with and 
without apical barriers. This article demonstrates the use of an apical matrix barrier in form of a platelet rich fibrin 
membrane for stabilization of MTA in root end apexification procedure. PRF is an autologous fibrin matrix con-
taining a large quantity of platelet and leukocyte cytokines, which enhance healing by release of growth factors. 
These case reports present apexification and successful healing with combined use of MTA and PRF membrane as 
an apical barrier
Results: PRF membrane can serve as an efficient apical matrix for condensation of MTA. Combination of PRF 
membrane and MTA is an effective method for management of difficult cases of open apex. PRF is a strong fibrin 
membrane enriched with platelet and growth factors that accelerate periapical healing.
Key words: Apexification, apical barrier, platelet rich fibrin (PRF), mineral trioxide (MTA).
Khetarpal A, Chaudhry S, Talwar  S, Verma M. Endodontic management 
of open apex using MTA and platelet – rich fibrin membrane barrier: A 
newer matrix concept. J Clin Exp Dent. 2013;5(5):e291-4.
http://www.medicinaoral.com/odo/volumenes/v5i5/jcedv5i5p291.pdf
Article Number: 51178                http://www.medicinaoral.com/odo/indice.htm
© Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488
eMail:  jced@jced.es
Indexed in:
Scopus
DOI® System
doi:10.4317/jced.51178
http://dx.doi.org/10.4317/jced.51178
Introduction
MTA has been shown to be a very effective root fill-
ing material for sealing immature root canals with open 
apices that could otherwise impose technical challenges 
in obtaining adequate obturation. MTA has an ability to 
facilitate periradicular healing by inducing hard-tissue 
formation (1). But in some cases with wide open apices, 
adequate condensation of MTA is difficult to achieve as 
the material may get extruded beyond the apex. There-
fore an apical matrix is used for the controlled place-
ment of MTA to a desired level. Various biocompatible 
materials have been tried as apical matrix in the past. 
These include: tricalcium phosphate (2), collagen cal-
cium phosphate (3), osteogenic protein-1, bone growth 
factor and oxidized cellulose (4), proplast, (a polytetra-
fluor-ethylene and carbon felt-like porous material) (5), 
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barium hydroxide (6), true bovine bone ceramics, and 
dentin chips (7). “Modified matrix concept” for repair 
of perforation utilized resorbable collagen as a matrix 
followed by condensation of MTA (8).
Platelet-rich fibrin (PRF) developed in France by Chouk-
roun and Dohan (9) represents a new step in the platelet 
gel therapeutic concept. PRF is a matrix of autologous 
fibrin, in which are embedded a large quantity of plate-
let and leukocyte cytokines during centrifugation. PRF 
obtained from Choukroun’s technique is a strong fibrin 
membrane enriched with platelet and growth factors. 
The easily applied PRF membrane serves as a matrix to 
accelerate the healing of wound edges (10).
Therefore, present case reports highlight the nonsurgical 
management of symptomatic teeth with immature apices 
and large periapical radiolucencies using PRF membrane 
matrix and MTA to promote periapical healing. 
 
Case Report
- Case Report 1 
A 15-year-old male patient reported with a chief com-
plaint of a discolored maxillary right central incisor. His-
tory revealed that the patient had suffered trauma at the 
age of 8 years. Radiographic examination revealed an 
immature tooth with a wide open apex and a radiolucent 
area in proximity of the apex of the tooth (Fig. 1). Endo-
dontic access opening was done under local anesthesia , 
and a periapical radiograph was taken to determine the 
working length. The root canal was lightly cleaned with 
a hand file under irrigation with 1.3% NaOCl. The root 
canal was then dried with sterile paper points. Calcium 
hydroxide was placed in the root canal, and the patient 
was recalled after one week. One week later, the tooth 
was again isolated under rubber dam, the calcium hy-
droxide dressing was removed by hand instrumentation, 
and irrigation was done with 1.3% NaOCl and 17% liq-
uid EDTA Smear Clear (SybronEndo, CA, USA). The 
root canal was then dried with sterile paper points. 
PRF membrane was used in the formation of the arti-
ficial barrier. Patient’s whole blood was drawn into 10 
ml glass coated plastic tubes using PRF collection kit 
without anticoagulant and  immediately centrifuged in 
Process® centrifuge (PC-02, Process Ltd., Nice, Fran-
ce) (Fig. 2) at 3000rpm for 10 minutes. Three layers 
got formed in the tube (Fig. 2): a base of RBCs, at the 
bottom, acellular plasma on the surface, and PRF clot in 
the middle. The fibrin clot was easily separated from the 
lower part of the centrifuged blood. The PRF clot was 
gently pressed into a membrane with a sterile dry gauge 
(11) (Fig. 2).
The membrane was packed against the bone and was 
pushed beyond the apex into the bony space formed due 
to the periapical lesion to form a matrix for the place-
ment of MTA (Fig. 2).
Fig. 1. a) Diagnostic radiograph; b) MTA plug; c) Post obturation ra-
diograph; d) Healing evident after 3 months.
Fig. 2. a) Centrifuge; b) 3 layers: top is platelet poor plasma, middle 
is PRF, and bottom layer contains red blood cells (RBC’s); c) PRF 
membrane in gauze; d) Carrying PRF membrane in the canal to form 
matrix.
A thick mixture of White Proroot MTA (Dentsply, Swit-
zerland) was then prepared and applied to the apical por-
tion of the canal using a small plugger and the butt end 
of sterile paper points (Fig. 1) and excess material was 
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after 2 weeks. Patient was asymptomatic at the recall ap-
pointment. The medicament was removed from the ca-
nal followed by irrigation with 1.25% sodium hypochlo-
rite. The apical matrix/barrier was created by carrying 
PRF membrane through the canal using hand pluggers 
(Dentsply, India) and packing it in periapical area (Fig. 
3). This was followed by a placement of 5 mm apical 
plug of white PROROOT MTA (MTA ™ Dentsply, In-
dia) using a finger plugger. The patient was asymptom-
atic at 1-week recall visit. Therefore, remaining canal 
was obturated using resin-based endodontic sealer (AH 
26, Dentsply India) and thermoplasticized gutta percha 
(Obtura II, J. Morita Corporation, Japan) (Fig. 3). The 
9-month follow-up radiograph of the patient showed re-
duction in the size of the periapical lesion (Fig. 3).
 
Discussion
The major problem in cases of a wide open apex is the 
need to limit the material, thus avoiding the extrusion of 
a large amount of material into the periodontal tissue. 
Using a matrix avoids the extrusion of the material into the 
periodontal tissues, reduces leakage in the sealing material 
and allows favorable response of the periodontal tissues. 
The apical barrier technique utilizing calcium sulfate 
or a combination of calcium sulfate and collagen in a 
powdered form has been performed in the past. Various 
materials have been used for formation of apical barrier 
during apexification. This case report has introduced a 
new concept of using PRF as an apical matrix membrane. 
PRF is a matrix of autologous fibrin, in which are em-
bedded a large quantity of platelet and leukocyte cytok-
ines during centrifugation (9). The intrinsic incorpora-
tion of cytokines within the fibrin mesh allows for their 
progressive release over time (7-11 days), as the network 
of fibrin disintegrates.(11) The easily applied PRF mem-
brane acts much like a fibrin bandage serving as a matrix 
to accelerate the healing of wound edges (13).
According to Simonpieri et al (2009) (14), the use of this 
platelet and immune concentrate offers the following 4 
advantages: First, the fibrin clot plays an important me-
chanical role, with the PRF membrane maintaining and 
protecting the grafted biomaterials and PRF fragments 
serving as biological connectors between bone particles. 
Second, the integration of this fibrin network into the re-
generative site facilitates cellular migration, particularly 
for endothelial cells necessary for the neo-angiogenesis 
(9), vascularization and survival of the graft. Third, the 
platelet cytokines (PDGF, TGF- , IGF-1) are gradually 
released as the fibrin matrix is resorbed, thus creating a 
perpetual process of healing (15). Lastly, the presence of 
leukocytes and cytokines in the fibrin network can play 
a significant role in the self-regulation of inflammatory 
and infectious phenomena within the grafted material.
The combination of PRF membrane as a matrix and 
MTA has been demonstrated to be an effective alterna-
cleared from the walls. Moistened gauze was placed in the 
remainder of the canal and the access cavity sealed using 
glass ionomer cement (Fuji, GC Corporation, Tokyo, Ja-
pan). Gutta percha backfill was performed using Obtura 
(Obtura/Spartan, Fenton, MO, USA), and the access cav-
ity was sealed using composite resin (Fig. 1) A radiograph 
confirmed the completion of the endodontic therapy. 
A 3-month follow- up revealed complete periapical heal-
ing and bone formation (Fig. 1).
The clinical follow-up at one year showed the patient 
functioning well with no reportable clinical symptoms 
and an absence of any sinus tract formation. The radio-
graphic follow-up at one year showed complete healing 
of the periapical radiolucency and regeneration of the 
periradicular tissues.
- Case Report 2 
A 17-year-old woman sought treatment for pain and 
swelling in the maxillary anterior region. Both the cen-
tral incisors were discoloured and had severe tenderness 
to percussion. IOPA Xray (Fig. 3) revealed open apices 
and large periapical radiolucency in relation to these 
teeth.Although surgical removal of the periapical le-
sion was also an available option, nonsurgical treatment 
was opted considering the age and amount of trauma 
expected during surgical treatment. Endodontic therapy 
was started and thorough biomechanical preparation 
was done using involving circumferential filling with 
a size 80 K file (Dentsply, India). Thereafter, calcium 
hydroxide was placed in canal and patient was recalled 
Fig. 3. a) Preoperative radiograph; b) MTA plug; c) Post obturation 
radiograph; d) Healing eident after 3 months.
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tive for creating artificial root-end barriers and to induce 
faster periapical healing for single visit apexification 
of the cases with large periapical lesions. The precise 
mechanism of action of PRF is yet to be proved. PRF 
is a second generation platelet concentrate which is still 
under study and many more advancements in its clinical 
applications are expected in near future.
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